Press release
Antibody Drug Conjugate Market Worldwide Highest CAGR 19% with Healthy Evolving Future Growth Rate, Key Trends, Competitive Landscape and Forecasts to 2023
Antibody Drug Conjugate Market
Global Antibody Drug Conjugate - Key Players
Some major players in the global antibody drug conjugate market include Seattle Genetics (US), ImmunoGen, Inc. (US), Roche Holding AG (Switzerland), Genentech (US), Concortis Biotherapeutics (US), Agensys, Inc. (US), Antikor (UK), Immunomedics (US), Pfizer Inc. (US), Celldex Therapeutics (US), Millennium Pharmaceuticals (US), AbbVie Inc. (US), Bayer HealthCare (Germany), Astellas Pharma/Agensys (Japan), Progenics Pharmaceuticals (US), Mersana Therapeutics (US), Synthon (US), Heidelberg Pharma (Germany), Oxford BioTherapeutics (US), and others.
Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/1113
Global Antibody Drug Conjugate - Market Scenario
The combine effect of targeting specific types of cells and the killing ability of cytotoxic drugs make this drug conjugate the ideal one for treatment of various cancers. The success of this technology has become possible only with increasing technological advancements.
The potential of a cytotoxic drug embedded in the antibody drug conjugate is increased by 100–1000 fold more than the potential of cytotoxic drug when it acts alone.
The advancement in the medical technology is driving the global market for antibody drug conjugates. Further over, preclinical research, the increasing research activities on antibody therapies, more research on advanced drug discoveries, increasing research on oncology diseases, the growing collaboration between research institutes, and biopharmaceuticals and biotechnology companies are acting as a fuel to the market and are expected to drive the market of antibody drug conjugates within the forecast period.
The global market of antibody drug conjugate is expected to grow at a CAGR of approximately 19% during the forecast period, 2017–2023.
Global Antibody drug conjugate Market - Highlights
Antibody drug conjugates are the targeted therapy for the treatment of people suffering with cancer. It is the important class of highly potent biopharmaceutical drugs, with intend to target and kill only cancer cells. Antibody drug conjugates have quality of sensitive discrimination between healthy and diseased tissue.
It represent an innovative therapeutic application that combines the unique, high specificity, properties and anti-tumor activity of monoclonal antibodies (mAbs) that are tumor-specific but not sufficiently cytotoxic. According to National Instituted of Health (NIH) it has been found that in 2016, a projected 1,685,210 new cases of cancer will be detected in the United States and 595,690 individuals will die from the disease which further increases the growth of the market.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market-1113
Global Antibody Drug Conjugate - Segmentation
The global antibody drug conjugate market is segmented on the basis of type, product, technology, application, and end-user.
On the basis of type, the global antibody drug conjugate market is segmented into monoclonal antibodies, linker, drug/toxin, and others.
On the basis of application, the global antibody drug conjugate market is segmented into leukemia, prostate cancer, kidney cancer, pancreas cancer, ovary cancer, glioblastoma, lung cancer, colon cancer, breast cancer, skin cancer, solid tumors, multiple myeloma, lymphoma, and other cancers. The leukemia segment is further divided into Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Acute Lymphocytic Leukemia (ALL), and Chronic Lymphocytic Leukemia (CLL).
On the basis of product, the global antibody drug conjugate market is segmented into Adcertis, Kadcyla, and others.
On the basis of technology, the global antibody drug conjugate market is classified into ImmunoGen technology, Seattle Genetics technology, Immunomedics technology, and others.
On the basis of end-user, the global antibody drug conjugate market is classified into hospitals, specialized cancer centers, academic research institutes, biotechnology companies, biopharmaceutical companies, and others.
Global Antibody Drug Conjugate - Intended Audience
Antibody drug conjugate manufacturing companies
Suppliers and distributors of antibody drug conjugate
Healthcare service providers
Health insurance players
Research and consulting firms
Medical research institutes
Venture capitalists
Community centers
Global Antibody Drug Conjugate - Regional Analysis
The global antibody drug conjugate market consists of four regions, namely, America, Europe, Asia Pacific, and the Middle East and Africa.
Americas dominated the global antibody drug conjugate market owing to the technological innovation, advancement in manufacturing processes, contribution of nanotechnology for developing Antibody Drug Conjugates (ADC). There are only three antibody drug conjugates that have received approval from the U.S. Food and Drug Administration (FDA). The US is the largest market among other countries such as Mexico, Canada, and others. Though, this technology is being developed by many large pharmaceutical companies, the success rate is of developing an ADC very less and lies with very few companies.
The European antibody drug conjugate market is the second largest market followed by the Asia Pacific regions.
Asia Pacific is the emerging market in the global antibody drug conjugate market. The rising awareness among consumers along with growing government initiatives are driving the antibody drug conjugate market in this region. There are many products under the pipeline. These developments are carried out under license agreements.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Antibody Drug Conjugate Market, By Type
Chapter 7. Global Antibody Drug Conjugate Market, By Application
Chapter 8. Global Antibody Drug Conjugate Market, By Product
Chapter 9. Global Antibody Drug Conjugate Market, By Technology
Chapter 10. Global Antibody Drug Conjugate Market, By End-User
Chapter. 11 Global Antibody Drug Conjugate Market, By Region
Chapter 12 Company Landscape
Chapter 13 Company Profiles
Chapter 14 MRFR Conclusion
Chapter 15 Appendix
Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/1113
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Drug Conjugate Market Worldwide Highest CAGR 19% with Healthy Evolving Future Growth Rate, Key Trends, Competitive Landscape and Forecasts to 2023 here
News-ID: 1155104 • Views: …
More Releases from Market Research Future
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics.
The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over…
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more.
The Palm Methyl Ester Derivative Market Size was valued at USD 1.5…
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences.
Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2…
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further.
APAC Wallpaper Market Size was valued at USD 0.55…
More Releases for Antibody
Antibody Engineering Services Market Size, Share | Industry Report, 2021-2027| F …
Complete study of the global Antibody Engineering Services market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Antibody Engineering Services industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They…
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.
Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515
Monoclonal Antibody Custom Service Market – Overview
It is estimated that monoclonal antibody custom service market is expected to…
Global In-depth analysis and Growth of Market Study on Combination Antibody Ther …
"Global Market Study on Combination Antibody Therapy: Antibody/Antibody Combination Segment Expected to Dominate the Global Market Through 2024" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
. …
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli
Scope of the Report:
This report focuses on the Procalcitonin…
Cancer Antibody Drug Conjugates Market Cancer Antibody Drug Conjugates Clinical …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Impetus of Antibody Drug Conjugates
1.1 Prologue to Cancer Antibody Drug Conjugate
1.2 The ABCs of ADCs
Structural Entities of Antibody Drug Conjugate
2.1 Rational Design of Antibody Drug Conjugates
2.1.1 Monoclonal Antibody
2.1.2 Linker
2.1.3 Drug Payload
2.2 Aspects of Conjugational Chemistry
Revolutionizing Antibody Drug Conjugates Generation
…
